Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Applied Molecular Transport
A Phase 2 12-week, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy of AMT-101 in Subjects with Chronic Antibiotic-resistant Pouchitis
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Chronic or recurrent pouchitis
You may not be if
Known gastrologic, or systemic condition that may compromise severity or diagnosis of disease.
History or current evidence of colonic or abdominal abnormalities.
Previous exposure to AMT-101 or similar and known hypersensitivity to AMT-101 or its excipients.
